World Vaccine Congress 2022

Unmatched experience bringing vaccines to market

With unprecedented innovation and number of vaccines in development globally, significant investments are being made to prevent disease, which is leading to an increasingly competitive race to market.

New challenges related to equitable distribution, engagement with consumers, HCPs, IDNs, payers, policy and even regulatory dynamics, make choosing the right partner for bringing your vaccine to market globally more important than ever.

Experts throughout the product development lifecycle

Our unique approach brings experts under one roof across clinical and commercial to create a Global Vaccine Center of Excellence that can help navigate your challenges and solve them more quickly, increasing the likelihood of regulatory approval and maximizing commercial success.

Roundtable: What Have We Really Learned From
COVID-19 — And Will We Be Better Prepared for the Next Pandemic?

Tuesday, April 19^th | 11:40午前 ET

Accelerating Drug and Vaccine Development During Infectious Disease Outbreaks

Wednesday, April 20^th | 12:10午後 ET

Lynlee Burton, MBA

Vice President, Clinical Development, Vaccines, Syneos Health

Darin Seehafer

Executive Director, Infectious Diseases and Vaccines, Syneos Health

詳細に興味がおありですか？ Explore Insights Hub for the latest industry perspectives, subscribe to our podcast, or click on the resources below:

COVID-19に関するインサイト

Fact Sheet: Vaccines Center of Excellence

Article: Quest for Outbreak Preparedness

Fact Sheet: Zika Outbreak

Case Study: Maternal RSV Immunization

AnswersOn: ワクチン

The Syneos Health Podcast, Coronavirus Special Edition: The Clinical Experience